Prevention of community-acquired pneumonia among a cohort of hospitalized elderly: Benefit due to influenza and pneumococcal vaccination not demonstrated

Dear K, Andrews RM, Holden J, Tatham DP. Vaccines for preventing pneumococcal infection in adults. Cochrane Database of Systematic Reviews 2003; Issue 4, Art. No.: CD000422. Govaert, 1994, The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial, JAMA, 272, 1661, 10.1001/jama.1994.03520210045030 Kaufman, 1947, Pneumonia in old age. Active immunization with pneumococcus polysaccharide: results of a six year study, Arch Intern Med, 79, 518, 10.1001/archinte.1947.00220110058004 MacLeod, 1945, Prevention of pneumococcal pneumonia by immunization with specific capsular polysaccharides, J Exp Med, 82, 445, 10.1084/jem.82.6.445 Austrian, 1976, Prevention of pneumococcal pneumonia by vaccination, Trans Assoc Am Physicians, 89, 184 Riley, 1977, Immunisation with a polyvalent pneumococcal vaccine. Reduction of adult respiratory mortality in a New Guinea Highlands community, Lancet, 1, 1338, 10.1016/S0140-6736(77)92552-1 Gaillat, 1985, Clinical trial of an antipneumococcal vaccine in elderly subjects living in institutions, Rev Epidemiol Sante Publique, 33, 437 Nichol, 1999, The health and economic benefits associated with pneumococcal vaccination of elderly persons with chronic lung disease, Arch Intern Med, 159, 2437, 10.1001/archinte.159.20.2437 Christenson, 2001, Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older: a prospective study, Lancet, 357, 1008, 10.1016/S0140-6736(00)04237-9 Wagner, 2003, Impact of pneumococcal vaccination on morbidity and mortality of geriatric patients: a case-controlled study, Gerontology, 49, 246, 10.1159/000070405 Jackson, 2003, Effectiveness of pneumococcal polysaccharide vaccine in older adults, N Engl J Med, 348, 1747, 10.1056/NEJMoa022678 Ansaldi, 2005, Effectiveness of a 23-valent polysaccharide vaccine in preventing pneumonia and non-invasive pneumococcal infection in elderly people: a large-scale retrospective cohort study, J Int Med Res, 33, 490, 10.1177/147323000503300503 Vila-Córcoles, 2006, Protective effects of the 23-valent pneumococcal polysaccharide vaccine in the elderly population: The EVAN-65 Study, Clin Infect Dis, 43, 860, 10.1086/507340 Jefferson, 2005, Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review, Lancet, 366, 1165, 10.1016/S0140-6736(05)67339-4 Hara, 2006, Effectiveness of influenza vaccination in preventing influenza-like illness among community-dwelling elderly: population-based cohort study in Japan, Vaccine, 24, 5546, 10.1016/j.vaccine.2006.04.027 Voordouw, 2003, Influenza vaccination in community-dwelling elderly: impact on mortality and influenza-associated morbidity, Arch Intern Med, 163, 1089, 10.1001/archinte.163.9.1089 Voordouw, 2006, Annual influenza vaccination in community-dwelling elderly individuals and the risk of lower respiratory tract infections or pneumonia, Arch Intern Med, 166, 1980, 10.1001/archinte.166.18.1980 Jackson, 2006, Evidence of bias in estimates of influenza vaccine effectiveness in seniors, Int J Epidemiol, 35, 337, 10.1093/ije/dyi274 Forrest, 2000, Pneumococcal disease in Australia, Commun Dis Intell, 24, 89 Comstock, 1994, Evaluating vaccination effectiveness and vaccine efficacy by means of case–control studies, Epidemiol Rev, 16, 77, 10.1093/oxfordjournals.epirev.a036147 Wacholder, 1991, Practical considerations in choosing between the case–cohort and nested case–control designs, Epidemiology, 2, 155, 10.1097/00001648-199103000-00013 Greenland, 1986, Adjustment of risk ratios in case-base studies (hybrid epidemiologic designs), Stat Med, 5, 579, 10.1002/sim.4780050605 Rothman, 1998, Case–control studies, 93 Smith, 1984, Assessment of the protective efficacy of vaccines against common diseases using case–control and cohort studies, Int J Epidemiol, 13, 87, 10.1093/ije/13.1.87 Rothman, 1998, Meta-analysis, 643 National Centre for Classification in Health. International statistical classification of diseases and related health problems, 10th ed. Sydney: University of Sydney; 1998 [Australian modification]. Last, 1995 MacIntyre, 2003, A randomised, clinical trial comparing the effectiveness of hospital and community-based reminder systems for increasing uptake of influenza and pneumococcal vaccine in hospitalised patients aged 65 years and over, Gerontology, 49, 33, 10.1159/000066500 StataCorp LP. Intercooled Stata 9.1 for Windows. 9.1 ed. TX: StataCorp LP, College Station; 2005. Watts, 2003, Establishing thresholds for influenza surveillance in Victoria, Aust N Z J Public Health, 27, 409, 10.1111/j.1467-842X.2003.tb00418.x Honkanen, 1999, Incremental effectiveness of pneumococcal vaccine on simultaneously administered influenza vaccine in preventing pneumonia and pneumococcal pneumonia among persons aged 65 years or older, Vaccine, 17, 2493, 10.1016/S0264-410X(99)00069-9 Koivula, 1997, Clinical efficacy of pneumococcal vaccine in the elderly: a randomized, single-blind population-based trial, Am J Med, 103, 281, 10.1016/S0002-9343(97)00149-6 Assendelft, 2004, Pneumococcal vaccination for the elderly in the Netherlands? Assessment of the quality and content of available comparative studies, Netherlands J Med, 62, 36 Fedson, 2004, Precise answers to the wrong question: prospective clinical trials and the meta-analyses of pneumococcal vaccine in elderly and high-risk adults, Vaccine, 22, 927, 10.1016/j.vaccine.2003.09.027 Skull, 2007, Pneumococcal polysaccharide vaccine may not prevent hospitalisation with pneumonia in elderly individuals, Clin Infect Dis, 44, 617, 10.1086/510490 Rivetti D, Jefferson T, Thomas R, Rudin M, Rivetti A, Di Pietrantonj C, et al. Vaccines for preventing influenza in the elderly. Cochrane Database of Systematic Reviews 2006; Issue 3, Art. No.: CD004876. Vu, 2002, A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community, Vaccine, 20, 1831, 10.1016/S0264-410X(02)00041-5 Rubins, 1999, Determination of antibody responses of elderly adults to all 23 capsular polysaccharides after pneumococcal vaccination [In Process Citation], Infect Immun, 67, 5979, 10.1128/IAI.67.11.5979-5984.1999 Squarcione, 2003, Comparison of the reactogenicity and immunogenicity of a split and a subunit-adjuvanted influenza vaccine in elderly subjects, Vaccine, 21, 1268, 10.1016/S0264-410X(02)00401-2 Murasko, 2002, Role of humoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly, Exp Gerontol, 37, 427, 10.1016/S0531-5565(01)00210-8 Lim, 1989, A prospective hospital study of the aetiology of community-acquired pneumonia, Med J Aust, 151, 87, 10.5694/j.1326-5377.1989.tb101168.x Wilson, 2005, Severe community-acquired pneumonia: an Australian perspective, Intern Med J, 35, 699, 10.1111/j.1445-5994.2005.00962.x Neill, 1996, Community acquired pneumonia: aetiology and usefulness of severity criteria on admission, Thorax, 51, 1010, 10.1136/thx.51.10.1010 Fedson, 1994, Pneumococcal vaccine, 517 Ruiz-Gonzalez, 1999, Is Streptococcus pneumoniae the leading cause of pneumonia of unknown etiology? A microbiologic study of lung aspirates in consecutive patients with community-acquired pneumonia, Am J Med, 106, 385, 10.1016/S0002-9343(99)00050-9 Watson, 2003, Laboratory surveillance of invasive pneumococcal disease in Australia in 2001 to 2002—implications for vaccine serotype coverage, Commun Dis Intell, 27, 478 Roche, 2002, Invasive pneumococcal disease in Australia, 2001, Commun Dis Intell, 26, 505 Hogg, 2000, Invasive pneumococcal disease in the population of Victoria, Med J Aust, 173, S32 Roche, 2004, Invasive pneumococcal disease in Australia, 2003, Commun Dis Intell, 28, 441 Jackson, 2005, Alcohol and ischaemic heart disease: probably no free lunch, Lancet, 366, 1911, 10.1016/S0140-6736(05)67770-7 Feinsten, 1986, An analysis of Berkson's bias in case–control studies, J Chronic Dis, 39, 495, 10.1016/0021-9681(86)90194-3 Andrews, 2005, Assessment of vaccine coverage following the introduction of a publicly funded pneumococcal vaccine program for the elderly in Victoria, Australia, Vaccine, 23, 2756, 10.1016/j.vaccine.2004.11.039 Dominguez, 2005, Effectiveness of pneumococcal vaccination for elderly people in Catalonia, Spain: a case–control study, Clin Infect Dis, 40, 1250, 10.1086/429236 Fine, 1994, Efficacy of pneumococcal vaccination in adults. A meta-analysis of randomized controlled trials, Arch Intern Med, 154, 2666, 10.1001/archinte.1994.00420230051007 Moore, 2000, Are the pneumococcal polysaccharide vaccines effective? Meta-analysis of the prospective trials, BMC Fam Pract, 1, 1, 10.1186/1471-2296-1-1 Watson, 2002, Pneumococcal polysaccharide vaccine: a systematic review of clinical effectiveness in adults, Vaccine, 20, 2166, 10.1016/S0264-410X(02)00112-3